Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

346.66 -6.68 (-1.89%)
Delayed Quote Updated: 12:46 PM EST, Nov 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Charles River Laboratories to Acquire Frontage’s Bioanalysis and DMPK Businesses
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Third-Quarter 2026 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Leverages Virtual Control Groups in GLP Studies
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
From Charles River Laboratories
Via Business Wire
News headline image
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Autolomous Partner to Transform Laboratory Execution Systems
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at Morgan Stanley and Baird Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Second-Quarter 2026 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at William Blair and Jefferies Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
From Charles River Laboratories
Via Business Wire
News headline image
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces First-Quarter 2026 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities
From Charles River Laboratories
Via Business Wire
News headline image
Charles River Highlights Effectiveness of VCGs in Toxicology
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at TD Cowen and Barclays Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Provides Update on Planned Divestitures
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Executive Appointments
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.